Treatment guidelines do not give a definite upper limit for basal insulin dose, and there may be the temptation to continue with a familiar routine by increasing the basal insulin dose despite the patient still not achieving glycemic targetsa situation known as over-basalization [10]
(2009) conducted a placebo-controlled experiment to assess the effectiveness of ROSE-010 in relieving pain in all IBS subtypes
Hair loss concerns arise frequently in GLP-1 medication discussions
Genetic variants in GIPR and FTO, and MC4R regions are associated with differing appetite regulation and weight loss response patterns
Call 911 or seek immediate medical attention if you experience: Black, tarry stools or blood in vomit (coffee-ground appearance), which may indicate gastrointestinal bleeding Severe or persistent abdominal pain that differs from typical semaglutide-related discomfort Sudden onset of chest pain, shortness of breath, or symptoms of heart attack or stroke Signs of allergic reaction, including rash, swelling, or difficulty breathing Decreased urine output, swelling in the legs or feet, or other signs of kidney problems Semaglutide can rarely cause pancreatitis